Dmitry Balyasny’s Editas Medicine EDIT Stock Holding History
Bought
Maintained
Sold
Other funds holding EDIT
Dmitry Balyasny's EDIT Position: Q3 2026 in Review
Dmitry Balyasny sold out of Editas Medicine (EDIT) in Q3 2026, closing a stake of 37,638 shares — an estimated $122K sold.
Dmitry Balyasny first reported a position in EDIT in Q3 2016 and held it in 17 quarters. The position peaked at $3.72M in Q2 2022. 219 funds tracked by Wall St. Rank hold EDIT as of Q3 2026.
- Dmitry Balyasny reported no remaining Editas Medicine position as of Q3 2026 after selling out during the quarter.
- Dmitry Balyasny sold 37,638 Editas Medicine shares in Q3 2026, an estimated $122K.
- Dmitry Balyasny first reported a position in Editas Medicine in Q3 2016 and held it in 17 quarters.
- Dmitry Balyasny's Editas Medicine position peaked at $3.72M in Q2 2022.
- 219 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2026.
Based on Balyasny Asset Management's 13F filing for Q3 2026, filed 16 Nov 2026.